ET
RMD icon

Entropy Technologies’s ResMed RMD Stock Holding History

Entropy Technologies’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641K Sell
3,291
-34,328
-91% -$7.11M 0.03% 610
2026
Q1 		$8.44M Buy
37,619
+19,298
+105% +$4.81M 0.39% 74
2025
Q4 		$4.41M Buy
18,321
+1,804
+11% +$461K 0.24% 118
2025
Q3 		$4.52M Buy
16,517
+133
+0.8% +$36.3K 0.34% 78
2025
Q2 		$4.23M Buy
16,384
+10,708
+189% +$2.55M 0.34% 71
2025
Q1 		$1.27M Buy
5,676
+4,587
+421% +$1.07M 0.12% 226
2024
Q4 		$249K Sell
1,089
-6,581
-86% -$1.58M 0.03% 581
2024
Q3 		$1.87M Buy
+7,670
New +$1.71M 0.2% 154
2024
Q2 		– Sell
-3,082
Closed -$610K – 900
2024
Q1 		$610K Sell
3,082
-16,988
-85% -$3.11M 0.07% 393
2023
Q4 		$3.45M Buy
+20,070
New +$3.08M 0.64% 13

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Entropy Technologies's RMD Position: Q2 2026 in Review

Entropy Technologies reduced its ResMed (RMD) stake by 91% in Q2 2026, selling an estimated $7.11M and leaving 3,291 shares worth $641K. The position accounts for 0.03% of the portfolio, ranked #610.

Entropy Technologies first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.44M in Q1 2026. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Entropy Technologies held 3,291 shares of ResMed worth $641K as of Q2 2026.
  • Entropy Technologies sold 34,328 ResMed shares in Q2 2026, an estimated $7.11M.
  • ResMed made up 0.03% of Entropy Technologies's portfolio in Q2 2026, its #610 holding.
  • Entropy Technologies first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
  • Entropy Technologies's ResMed position peaked at $8.44M in Q1 2026.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.